C/EBPα mutations in acute myeloid leukaemias
Top Cited Papers
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 4 (5) , 394-400
- https://doi.org/10.1038/nrc1363
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The CCAAT Enhancer-binding Protein α (C/EBPα) Requires a SWI/SNF Complex for Proliferation ArrestJournal of Biological Chemistry, 2004
- C/EBPϵ interacts with retinoblastoma and E2F1 during granulopoiesisBlood, 2004
- Disruption of differentiation in human cancer: AML shows the wayNature Reviews Cancer, 2003
- Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of theC/EBP? geneGenes, Chromosomes and Cancer, 2002
- CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemiaBlood, 2002
- Expression of C/EBPβ from the C/ebpα gene locus is sufficient for normal hematopoiesis in vivoBlood, 2002
- Cooperation between C/EBPα TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiationGenes & Development, 2001
- C/EBPε −/− mice: increased rate of myeloid proliferation and apoptosisLeukemia, 2001
- C/EBPα Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated TranscriptionMolecular and Cellular Biology, 2000
- Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.Genes & Development, 1994